Tulsa, OKNCT07695389Now EnrollingIRB Ready

Mohs Micrographic Surgery Clinical Trial in Tulsa, OK

Access cutting-edge mohs micrographic surgery treatment through this clinical trial at a research site in Tulsa. Study-provided care at no cost to qualified participants.

Sponsored by BioLab Holdings

Quick Self-Assessment

See if you qualify for this Tulsa location

Preparing your pre-screening questions…

Expert Care in Tulsa

Access mohs micrographic surgery specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related mohs micrographic surgery treatment provided free

Apply for This Tulsa Location

Check if you qualify for this mohs micrographic surgery clinical trial in Tulsa, OK

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Tulsa

    Convenient for OK residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Tulsa site if eligible
  4. 4Begin participation

About This Mohs Micrographic Surgery Study in Tulsa

A multicenter, prospective, randomized controlled clinical trial assessing the efficacy of a novel cellular, acellular, matrix-like product (CAMP) plus standard of care versus standard of care alone in the management of post-mohs micrographic surgery defects.

Sponsor: BioLab Holdings

Who Can Participate

Inclusion Criteria

The potential subject must be at least 18 years of age or older.
The potential subject must have undergone Mohs micrographic surgery for a cutaneous malignancy (e.g., basal cell carcinoma, or squamous cell carcinoma).
The potential subject must have a post-Mohs surgical defect that is suitable for treatment with a CAMP product or healing by secondary intention.
The surgical site has received standard Mohs excision and hemostasis with no requirement for immediate flap or graft reconstruction as determined by the treating surgeon.
If the surgical defect is on the lower extremity, the limb must have adequate perfusion confirmed by vascular assessment. Any of the following methods performed within 3 months of the first screening visit are acceptable:
Ankle-Brachial Index (ABI) between 0.7 and ≤ 1.3;
Toe-Brachial Index (TBI) ≥ 0.6;
Transcutaneous Oxygen Measurement (TCOM) ≥ 40 mmHg;
Pulse Volume Recording (PVR): biphasic.
If the subject has multiple Mohs defects, they must be separated by at least 2 cm. The largest defect satisfying the inclusion and

Exclusion Criteria

will be designated as the target wound.
The potential subject must agree to attend the weekly study visits required by the protocol.
The potential subject must be willing and able to participate in the informed consent process. Exclusion Criteria:
The potential subject is known to have a life expectancy of \< 6 months.
The potential subject's target wound is not secondary to a Mohs excision.
The target wound is infected or there is cellulitis in the surrounding skin.
The target wound:
Exposes tendon, bone, or joint space, and/or
Requires immediate complex flap or graft reconstruction in the judgment of the surgeon.
The potential subject has participated in a clinical trial involving treatment with an investigational product within the previous 30 days.
The potential subject has glycated hemoglobin (HbA1c) greater than 10% within 3 months of the initial screening visit.
The potential subject, in the opinion of the investigator, has a medical or psychological condition that may interfere with study assessments.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Tulsa?

Yes, this clinical trial (NCT07695389) has an active research site in Tulsa, OK that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Mohs Micrographic Surgery Treatment Options in Tulsa, OK

If you're searching for mohs micrographic surgery treatment options in Tulsa, OK, this clinical trial (NCT07695389) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Tulsa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced mohs micrographic surgery specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all mohs micrographic surgery clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Tulsa, OK

See all heart attack clinical trials recruiting in Tulsa — not just this study.

Browse Heart Attack Trials in Tulsa →

Browse More Trials by Condition

Heart Attack TrialsRheumatoid Arthritis TrialsPulmonary Hypertension TrialsHidradenitis Suppurativa TrialsInterstitial Cystitis TrialsMyocardial Infarction TrialsObesity Hypoventilation Syndrome TrialsAll Conditions →

Ready to Join in Tulsa?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Tulsa, OK